RadNet’s price performance momentum has led to a jump in its IBD Relative Strength Rating from 73 to 83. This upgrade reflects the company’s strengthening position in the market, as reported by Investor’s & Business Daily.

Ameriprise Financial Inc. has significantly expanded its stake in RadNet, Inc. by purchasing nearly half a million shares in the first quarter, bringing its total holdings to over three-quarters of a million. This move highlights growing confidence in RadNet’s role as a medical research company.